Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|April 13, 2013
Form and function in cyclic peptide natural products: a pharmacokinetic perspectiveAndrew T Bockus, Cayla M McEwen, R Scott LokeyCurrent Opinion in Chemical Biology|June 2, 2017
Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targetsMatthew R Naylor, Andrew T Bockus, Maria-Jesus Blanco, et al.Chemical Communications (Cambridge, England)|June 18, 2016
Predictive recognition of native proteins by cucurbit[7]uril in a complex mixtureWei Li, Andrew T Bockus, Brittany Vinciguerra, et al.Future Medicinal Chemistry|June 13, 2015
Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural productsChristopher L Ahlbach, Katrina W Lexa, Andrew T Bockus, et al.Bioconjugate Chemistry|December 19, 2022
Semisynthesis of Aminomethyl-Insulin: An Atom-Economic Strategy to Increase the Affinity and Selectivity of a Protein for Recognition by a Synthetic ReceptorHayden R Anderson, Wei L Reeves, Andrew T Bockus, et al.Journal of the American Chemical Society|September 18, 2018
Molecular Recognition of Methionine-Terminated Peptides by Cucurbit[8]urilZoheb Hirani, Hailey F Taylor, Emily F Babcock, et al.Journal of Medicinal Chemistry|August 27, 2015
Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A AnaloguesAndrew T Bockus, Joshua A Schwochert, Cameron R Pye, et al.Journal of the American Chemical Society|December 22, 2016
Cucurbit[7]uril-Tetramethylrhodamine Conjugate for Direct Sensing and Cellular ImagingAndrew T Bockus, Lauren C Smith, Amy G Grice, et al.Journal of Medicinal Chemistry|May 8, 2015
Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural ProductsAndrew T Bockus, Katrina W Lexa, Cameron R Pye, et al.Journal of Medicinal Chemistry|February 21, 2026
Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1-S-Checkpoint-Compromised CancersJustin A Shapiro, Nathan J Dupper, Breena Fraga-Walton, et al.Pageof 2